Rac1 repression reverses chemoresistance by targeting tumor metabolism

References

• Li Q, Qin T, Bi Z, Hong H, Ding L, Chen J, Wu W, Lin X, Fu W, Zheng F, et al. Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer. Nat Commun. 2020;11:1–18. doi:10.1038/s41467-020-15308-7.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. doi:10.1016/j.cell.2011.02.013.
   PubMed Web of Science ®Google Scholar
• Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4:891–899. doi:10.1038/nrc1478.
   PubMed Web of Science ®Google Scholar
• Ganapathy-Kanniappan S. Molecular intricacies of aerobic glycolysis in cancer: current insights into the classic metabolic phenotype. Crit Rev Biochem Mol Biol. 2018;53:667–682. doi:10.1080/10409238.2018.1556578.
   PubMed Web of Science ®Google Scholar
• Ganapathy-Kanniappan S, Geschwind JF. Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. 2013;12(1):152. doi:10.1186/1476-4598-12-152.
   PubMedGoogle Scholar
• Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB. Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev. 2008;18:54–61. doi:10.1016/j.gde.2008.02.003.
   PubMed Web of Science ®Google Scholar
• Patra KC, Hay N. The pentose phosphate pathway and cancer. Trends Biochem Sci. 2014;39:347–354. doi:10.1016/j.tibs.2014.06.005.
   PubMed Web of Science ®Google Scholar
• Yang X, Peng X, Huang J. Inhibiting 6-phosphogluconate dehydrogenase selectively targets breast cancer through AMPK activation. Clin Transl Oncol. 2018;20:1145–1152. doi:10.1007/s12094-018-1833-4.
   PubMed Web of Science ®Google Scholar
• Shan C, Lu Z, Li Z, Sheng H, Fan J, Qi Q, Liu S, Zhang S. 4-hydroxyphenylpyruvate dioxygenase promotes lung cancer growth via pentose phosphate pathway (PPP) flux mediated by LKB1-AMPK/HDAC10/G6PD axis. Cell Death Dis. 2019;10:1–13. doi:10.1038/s41419-019-1756-1.
   Web of Science ®Google Scholar
• Liu X, Olszewski K, Zhang Y, Lim EW, Shi J, Zhang X, Zhang J, Lee H, Koppula P, Lei G, et al. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. Nat Cell Biol. 2020;22:476–486. doi:10.1038/s41556-020-0496-x.
   PubMed Web of Science ®Google Scholar
• Gelman SJ, Naser F, Mahieu NG, McKenzie LD, Dunn GP, Chheda MG, Patti GJ. Consumption of NADPH for 2-HG synthesis increases pentose phosphate pathway flux and sensitizes cells to oxidative stress. Cell Rep. 2018;22:512–522. doi:10.1016/j.celrep.2017.12.050.
   PubMed Web of Science ®Google Scholar
• Zeng RJ, Zheng CW, Gu JE, Zhang HX, Xie L, Xu LY, Li EM. RAC1 inhibition reverses cisplatin resistance in esophageal squamous cell carcinoma and induces downregulation of glycolytic enzymes. Mol Oncol. 2019;13:2010–2030. doi:10.1002/1878-0261.12548.
   PubMed Web of Science ®Google Scholar
• Hirota K, Semenza GL. Rac1 activity is required for the activation of hypoxia-inducible factor 1. J Biol Chem. 2001;276:21166–21172. doi:10.1074/jbc.M100677200.
   PubMed Web of Science ®Google Scholar
• Xue Y, Bi F, Zhang X, Zhang S, Pan Y, Liu N, Shi Y, Yao X, Zheng Y, Fan D. Role of Rac1 and Cdc42 in hypoxia induced p53 and von hippel-lindau suppression and HIF1alpha activation. Int J Cancer. 2006;118:2965–2972. doi:10.1002/ijc.21763.
   PubMed Web of Science ®Google Scholar
• Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem. 1994;269:23757–23763.
   PubMed Web of Science ®Google Scholar
• Sweet RL, Zastre JA. HIF1-alpha-mediated gene expression induced by vitamin B1 deficiency. Int J Vitam Nutr Res. 2013;83:188–197. doi:10.1024/0300-9831/a000159.
   PubMed Web of Science ®Google Scholar
• Valli A, Morotti M, Zois CE, Albers PK, Soga T, Feldinger K, Fischer R, Frejno M, McIntyre A, Bridges E, et al. Adaptation to HIF1alpha deletion in hypoxic cancer cells by upregulation of GLUT14 and creatine metabolism. Mol Cancer Res. 2019;17:1531–1544. doi:10.1158/1541-7786.MCR-18-0315.
   PubMed Web of Science ®Google Scholar
• Bopp A, Wartlick F, Henninger C, Schwarz M, Kaina B, Fritz G. Rac1 promotes diethylnitrosamine (DEN)-induced formation of liver tumors. Carcinogenesis. 2015;36:378–389. doi:10.1093/carcin/bgu323.
   PubMed Web of Science ®Google Scholar
• Chatterjee N, Anwar T, Islam NS, Ramasarma T, Ramakrishna G. Growth arrest of lung carcinoma cells (A549) by polyacrylate-anchored peroxovanadate by activating Rac1-NADPH oxidase signalling axis. Mol Cell Biochem. 2016;420:9–20. doi:10.1007/s11010-016-2761-7.
   PubMed Web of Science ®Google Scholar
• Naci D, Berrazouane S, Barabe F, Aoudjit F. Cell adhesion to collagen promotes leukemia resistance to doxorubicin by reducing DNA damage through the inhibition of Rac1 activation. Sci Rep. 2019;9:1–13. doi:10.1038/s41598-019-55934-w.
   PubMed Web of Science ®Google Scholar
• Liu W, Chen G, Sun L, Zhang Y, Han J, Dai Y, He J, Shi S, Chen B. TUFT1 promotes triple negative breast cancer metastasis, stemness, and chemoresistance by up-regulating the Rac1/beta-catenin pathway. Front Oncol. 2019;9:617. doi:10.3389/fonc.2019.00617.
   PubMed Web of Science ®Google Scholar
• Guo H, Xiang Z, Zhang Y, Sun D. Inhibiting 6-phosphogluconate dehydrogenase enhances chemotherapy efficacy in cervical cancer via AMPK-independent inhibition of RhoA and Rac1. Clin Transl Oncol. 2019;21:404–411. doi:10.1007/s12094-018-1937-x.
   PubMed Web of Science ®Google Scholar
• Giacomini I, Ragazzi E, Pasut G, Montopoli M. 2020. The pentose phosphate pathway and its involvement in cisplatin resistance. Int J Mol Sci. 21(3):937. doi:10.3390/ijms21030937.
   PubMed Web of Science ®Google Scholar
• Choi J, Kim ES, Koo JS. Expression of pentose phosphate pathway-related proteins in breast cancer. Dis Markers. 2018;2018:9369358. doi:10.1155/2018/9369358.
   PubMed Web of Science ®Google Scholar
• Franklin DA, He Y, Leslie PL, Tikunov AP, Fenger N, Macdonald JM, Zhang Y. p53 coordinates DNA repair with nucleotide synthesis by suppressing PFKFB3 expression and promoting the pentose phosphate pathway. Sci Rep. 2016;6:38067. doi:10.1038/srep38067.
   PubMed Web of Science ®Google Scholar
• Ma X, Wang L, Huang LY, Yang D, Li T, Li F, Sun L, Wei H, He K, Yu F, et al. Polo-like kinase 1 coordinates biosynthesis during cell cycle progression by directly activating pentose phosphate pathway. Nat Commun. 2017;8: 1506-017-01647-5. doi:10.1038/s41467-017-01647-5.
   Web of Science ®Google Scholar